Recent News

• 05.15.2025 - Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
• 04.25.2025 - Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025
• 03.26.2025 - Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025
• 03.20.2025 - Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options

Recent Filings

• 05.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.05.2025 - 8-K Current report
• 04.24.2025 - ARS Annual Report to Security Holders
• 04.24.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.24.2025 - DEF 14A Other definitive proxy statements
• 04.16.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 04.11.2025 - PRE 14A Other preliminary proxy statements
• 04.04.2025 - 8-K Current report
• 04.01.2025 - 8-K Current report
• 03.26.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors